Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bloom Infant Probiotic (BIP) Study
NCT07189390Phase 2Recruiting
- Sponsor
- South Australian Health and Medical Research Institute
- Start
- May 2026
- Primary completion
- May 2029
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Infloran in Dysbiosis, sponsored by South Australian Health and Medical Research Institute. Started May 2026; status: recruiting.
02
Drugs
Infloran
03
Conditions
Dysbiosis
Beyond the preview
Go deeper on NCT07189390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07189390.